Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background and Aims: Carriage of rs738409:G in patatin‐like phospholipase domain containing 3 (PNPLA3) is associated with an increased risk for developing alcohol‐related cirrhosis and hepatocellular carcinoma (HCC). Recently, rs72613567:TA in hydroxysteroid 17‐beta dehydrogenase 13 (HSD17B13) was shown to be associated with a reduced risk for developing alcohol‐related liver disease and to attenuate the risk associated with carriage of PNPLA3 rs738409:G. This study explores the risk associations between these two genetic variants and the development of alcohol‐related cirrhosis and HCC. Approach and Results: Variants in HSD17B13 and PNPLA3 were genotyped in 6,171 participants, including 1,031 with alcohol‐related cirrhosis and HCC, 1,653 with alcohol‐related cirrhosis without HCC, 2,588 alcohol misusers with no liver disease, and 899 healthy controls. Genetic associations with the risks for developing alcohol‐related cirrhosis and HCC were determined using logistic regression analysis. Carriage of HSD17B13 rs72613567:TA was associated with a lower risk for developing both cirrhosis (odds ratio [OR], 0.79; 95% confidence interval [CI], 0.72‐0.88; P = 8.13 × 10−6) and HCC (OR, 0.77; 95% CI, 0.68‐0.89; P = 2.27 × 10−4), whereas carriage of PNPLA3 rs738409:G was associated with an increased risk for developing cirrhosis (OR, 1.70; 95% CI, 1.54‐1.88; P = 1.52 × 10−26) and HCC (OR, 1.77; 95% CI, 1.58‐1.98; P = 2.31 × 10−23). These associations remained significant after adjusting for age, sex, body mass index, type 2 diabetes, and country. Carriage of HSD17B13 rs72613567:TA attenuated the risk for developing cirrhosis associated with PNPLA3 rs738409:G in both men and women, but the protective effect against the subsequent development of HCC was only observed in men (OR allelic, 0.75; 95% CI, 0.64‐0.87; P = 1.72 × 10−4). Conclusions: Carriage of variants in PNPLA3 and HSD17B13 differentially affect the risk for developing advanced alcohol‐related liver disease. A genotypic/phenotypic risk score might facilitate earlier diagnosis of HCC in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“(22) The severity of the underlying cirrhosis was assessed using Pugh’s modification of Child’s grading system.(23) The patients with alcohol misuse but no evidence of significant liver injury were recruited as described in detail previously;(19) in brief, they had a background of alcohol consumption of at least 60 g/…”
MethodBurden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Data quality control in genetic case-control association studies
Anderson, C. A., Pettersson, F. H., Clarke, G. M., Cardon, L. R., Morris, A. P., & Zondervan, K. T. (2010) · Nature Protocols · doi:10.1038/nprot.2010.116 · Cited by 1,318 · cited 1×
“05).(26) In the healthy controls, the minor allele frequencies (MAFs) for both HSD17B13 rs72613567:TA (0.”
BackgroundA Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
Abul-Husn, N. S., Cheng, X., Li, A. H., Xin, Y., Schurmann, C., Stevis, P., Liu, Y., Kozlitina, J., Stender, S., Wood, G. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712191 · Cited by 827 · cited 16×
“The comparative survival advantage in women with alcohol-related cirrhosis is well documented,(31-33) and it has recently been shown that this may relate, at least in part, to a sex-variant interaction with rs738409:G in PNPLA3.”
BackgroundResultInfluentialGlobal burden of alcoholic liver diseases
Rehm, J., Samokhvalov, A. V., & Shield, K. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.007 · Cited by 740
Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3417 · Cited by 565
Self-citationHepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360 · cited 1×
“0%, with a 5-year cumulative risk of around 8%.(8-11) The global incidence of HCC is increasing; it is now the fifth-most-frequent cancer and third-most-frequent cause of cancer-related mortality worldwide; one third of cases develop on a background of alcohol-related cirrhosis.”
BackgroundLi, D., Zhao, H., & Gelernter, J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.024 · Cited by 165 · cited 1×
“Indirect protection is afforded in individuals, primarily those of East Asian ancestry, who carry rs1229984 in alcohol dehydrogenase 1B(28) and/or rs671 in aldehyde dehydrogenase 2(29) and, as a consequence, develop a reaction to alcohol and so tend to avoid it.”
BackgroundLi, D., Zhao, H., & Gelernter, J. (2012) · Human Genetics · doi:10.1007/s00439-011-1116-4 · Cited by 158 · cited 1×
“Indirect protection is afforded in individuals, primarily those of East Asian ancestry, who carry rs1229984 in alcohol dehydrogenase 1B(28) and/or rs671 in aldehyde dehydrogenase 2(29) and, as a consequence, develop a reaction to alcohol and so tend to avoid it.”
BackgroundCortes, E., Lachowski, D., Rice, A., Chronopoulos, A., Robinson, B., Thorpe, S., Lee, D. A., Possamai, L. A., Wang, H., Pinato, D. J., et al. (2019) · Hepatology · doi:10.1002/hep.30193 · Cited by 64 · cited 1×
“Retinoic acid depletion results in a functional down-regulation of liver retinoic acid receptors and a marked increase in the expression of the activator protein-1 (c-Jun and c-Fos) transcriptional complex, which is associated with hepatic cell hyperproliferation, a decrease in apoptosis, and stimulated hepatic carcin…”
Background
Cited by
Update on NAFLD genetics: From new variants to the clinic
Trépo, E., & Valenti, L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.020 · Cited by 393
Self-citationThe intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
“Moreover, carriage of the HSD17B13 rs72613567 T>A genetic variant has been associated with a protective effect against developing both cirrhosis and HCC in patients who misuse alcohol 172 .”
BackgroundRutledge, S. M., Soper, E. R., Ma, N., Pejaver, V., Friedman, S. L., Branch, A. D., Kenny, E. E., Belbin, G. M., & Abul-Husn, N. S. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.12.025 · Cited by 22
Li, Y., Li, Z., Chen, R., Lian, M., Wang, H., Wei, Y., You, Z., Zhang, J., Li, B., Li, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37213-5 · Cited by 18
Metadata
- Authors
- Stickel, F., Lutz, P., Buch, S., Nischalke, H. D., Silva, I., Rausch, V., Fischer, J., Weiss, K. H., Gotthardt, D., Rosendahl, J., Marot, A., Elamly, M., Krawczyk, M., Casper, M., Lammert, F., Buckley, T. W. M., McQuillin, A., Spengler, U., Eyer, F., Vogel, A., Marhenke, S., von Felden, J., Wege, H., Sharma, R., Atkinson, S., Franke, A., Nehring, S., Moser, V., Schafmayer, C., Spahr, L., Lackner, C., Stauber, R. E., Canbay, A., Link, A., Valenti, L., Grove, J. I., Aithal, G. P., Marquardt, J. U., Fateen, W., Zopf, S., Dufour, J., Trebicka, J., Datz, C., Deltenre, P., Mueller, S., Berg, T., Hampe, J., & Morgan, M. Y.
- Venue
- Hepatology
- Published
- 2020-05-20
- Volume
- 72
- Issue
- 1
- Pages
- 88-102
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2980926085
- Cited by
- 108
- References
- 10
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.